文献
J-GLOBAL ID:201102215127669550
整理番号:11A0002263
転移性腎細胞癌の日本人患者におけるスニチニブの第II相試験からの全生存期間および最新結果
Overall Survival and Updated Results from a Phase II Study of Sunitinib in Japanese Patients with Metastatic Renal Cell Carcinoma
著者 (15件):
TOMITA Yoshihiko
(Yamagata Univ. School of Medicine, Yamagata)
,
SHINOHARA Nobuo
(Hokkaido Univ. Graduate School of Medicine, Sapporo)
,
YUASA Takeshi
(Akita Univ. School of Medicine, Akita)
,
FUJIMOTO Hiroyuki
(National Cancer Center Hospital, Tokyo)
,
NIWAKAWA Masashi
(Shizuoka Cancer Center Hospital, Shizuoka)
,
MUGIYA Soichi
(Hamamatsu Univ. School of Medicine, Hamamatsu)
,
MIKI Tsuneharu
(Kyoto Prefectural Univ. Medicine, Kyoto)
,
UEMURA Hirotsugu
(Kinki Univ. School of Medicine, Osaka)
,
NONOMURA Norio
(Osaka Univ. Graduate School of Medicine, Osaka)
,
TAKAHASHI Masayuki
(Univ. Tokushima Graduate School, Tokushima)
,
HASEGAWA Yoshihiro
(National Kyushu Cancer Center Hospital, Fukuoka)
,
AGATA Naoki
(Pfizer Japan Inc., Tokyo)
,
HOUK Brett
(Pfizer Global Res. and Dev., CA, USA)
,
NAITO Seiji
(Kyushu Univ., Fukuoka)
,
AKAZA Hideyuki
(Univ. Tokyo, Tokyo, JPN)
資料名:
Japanese Journal of Clinical Oncology
(Japanese Journal of Clinical Oncology)
巻:
40
号:
12
ページ:
1166-1172
発行年:
2010年12月
JST資料番号:
W2222A
ISSN:
0368-2811
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
イギリス (GBR)
言語:
英語 (EN)